Metaphyseal Chondrodysplasia, Schmid Type (MCDS): Mechanistic Summary
Core genetics and inheritance
MCDS is caused by heterozygous pathogenic variants in COL10A1 and is inherited in an autosomal dominant pattern. Foundational segregation data demonstrated a COL10A1 deletion segregating with autosomal dominant MCDS in a large kindred (PMID:8220429). Subsequent series confirmed COL10A1 mutations across affected patients and reinforced autosomal dominant inheritance (PMID:16088909; PMID:15880705).
Pathophysiology
COL10A1 encodes type X collagen, which is specifically expressed in hypertrophic chondrocytes in growth plates during endochondral ossification (PMID:8220429; PMID:15695517). Disease mechanisms include:
- Collagen X quantitative/assembly defects: NC1-domain and truncating variants impair collagen X trimerization/secretion and reduce functional extracellular collagen X.
- Growth plate dysfunction: This drives metaphyseal abnormalities and altered endochondral bone growth (PMID:16088909).
- Protein misfolding and stress signaling: Mutant collagen X chains can be retained intracellularly and activate the unfolded protein response (UPR), including BiP upregulation and XBP1 splicing (PMID:15695517).
- Likely haploinsufficiency contribution: Review data suggest functional haploinsufficiency as a major proximate cause across mutation classes (PMID:15880705).
Hallmark clinical and radiographic phenotypes
Key features repeatedly reported include:
- Short stature
- Widened growth plates
- Bowing of long bones
- Lower limb deformities, frequently requiring orthopedic surgery
- Metaphyseal radiographic changes, often most pronounced around hips and knees
These are directly supported in a 10-patient clinical/radiographic cohort (PMID:16088909).
Clinical implications
MCDS severity varies substantially among affected individuals even within the same molecular diagnosis. Orthopedic burden is common, and clinical management is driven by deformity severity and growth trajectory (PMID:16088909).